| 393 |
[2021 Nov;45(6)] Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
|
|
2022.07.15 |
538 |
| 392 |
[2021 Nov;45(6)] Obesity, Diabetes, and Increased Cancer Progression
|
|
2022.07.15 |
540 |
| 391 |
[2021 Sep;45(5)] The Effects of Exercise and Restriction of Sugar-Sweetened Beverages on Muscle Function and Autophagy Regulation in High-Fat High-Sucrose-Fed Obesity Mice
|
|
2022.07.15 |
529 |
| 390 |
[2021 Sep;45(5)] Effects of Social Distancing on Diabetes Management in Older Adults during COVID-19 Pandemic
|
|
2022.07.15 |
507 |
| 389 |
[2021 Sep;45(5)] Appraisal of Guidelines for the Management of Blood Pressure in Patients with Diabetes Mellitus: The Consensuses, Controversies and Gaps
|
|
2022.07.15 |
544 |
| 388 |
[2021 Sep;45(5)] Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease
|
|
2022.07.15 |
531 |
| 387 |
[2021 Sep;45(5)] Maternal Hyperglycemia during Pregnancy Increases Adiposity of Offspring
|
|
2022.07.15 |
550 |
| 386 |
[2021 Sep;45(5)] Longitudinal Change in Myocardial Function and Clinical Parameters in Middle-Aged Subjects: A 3-Year Follow-up Study
|
|
2022.07.15 |
595 |
| 385 |
[2021 Sep;45(5)] Screening Tools Based on Nomogram for Diabetic Kidney Diseases in Chinese Type 2 Diabetes Mellitus Patients
|
|
2022.07.15 |
548 |
| 384 |
[2021 Sep;45(5)] Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
|
|
2022.07.15 |
526 |
| 383 |
[2021 Sep;45(5)] High Incidence of Chronic Kidney Disease among Iranian Diabetic Adults: Using CKD-EPI and MDRD Equations for Estimated Glomerular Filtration Rate
|
|
2022.07.15 |
639 |
| 382 |
[2021 Sep;45(5)] Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
|
|
2022.07.15 |
569 |
| 381 |
[2021 Sep;45(5)] Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
|
|
2022.07.15 |
504 |
| 380 |
[2021 Sep;45(5)] Assessment of Insulin Secretion and Insulin Resistance in Human
|
|
2022.07.15 |
548 |
| 379 |
[2021 Sep;45(5)] A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future
|
|
2022.07.15 |
558 |
| 378 |
[2021 Jul;45(4)] A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus
|
|
2022.07.15 |
530 |
| 377 |
[2021 Jul;45(4)] Role of Autophagy in Granulocyte-Colony Stimulating Factor Induced Anti-Apoptotic Effects in Diabetic Cardiomyopathy
|
|
2022.07.15 |
570 |
| 376 |
[2021 Jul;45(4)] Association of Combined TCF7L2 and KCNQ1 Gene Polymorphisms with Diabetic Micro- and Macrovascular Complications in Type 2 Diabetes Mellitus
|
|
2022.07.15 |
597 |
| 375 |
[2021 Jul;45(4)] Metabolic Syndrome Severity Score for Predicting Cardiovascular Events: A Nationwide Population-Based Study from Korea
|
|
2022.07.15 |
554 |
| 374 |
[2021 Jul;45(4)] Level of Organochlorine Pesticide in Prediabetic and Newly Diagnosed Diabetes Mellitus Patients with Varying Degree of Glucose Intolerance and Insulin Resistance among North Indian Population
|
|
2022.07.15 |
603 |
